| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 02/25/2010 | US20100048672 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 02/25/2010 | US20100048658 Fused heterocyclic compounds |
| 02/25/2010 | US20100048656 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048564 Fused bicyclic heteroaryl derivative |
| 02/24/2010 | EP2155893A2 Novel nitroreductase enzymatic substrates |
| 02/24/2010 | EP2155892A2 Novel peptidase substrates |
| 02/24/2010 | EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| 02/24/2010 | EP2154966A1 Benzimidazoles and pharmaceutical compositions thereof |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1542678B1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS |
| 02/24/2010 | CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/18/2010 | WO2010018874A1 Amide compound |
| 02/18/2010 | WO2010018441A2 An improved process for the preparation of substantially pure telmisartan |
| 02/18/2010 | US20100041891 Amide compound |
| 02/18/2010 | US20100039027 Organic electroluminescence device |
| 02/18/2010 | US20100039024 New Heterocyclic bridged biphenyls |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152674A1 Benzimidazolone chymase inhibitors |
| 02/16/2010 | US7662966 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions |
| 02/16/2010 | US7662841 Imidazothiazole derivatives and process for producing the same |
| 02/16/2010 | CA2440037C Benzimidazole derivatives for modulating the rage receptor |
| 02/11/2010 | WO2010017401A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
| 02/11/2010 | WO2010016549A1 Tricyclic compound |
| 02/11/2010 | US20100035951 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/10/2010 | EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents |
| 02/09/2010 | US7659026 membrane electrodes; electrocatalysts; fuel cells |
| 02/04/2010 | WO2010013835A2 Solid pharmaceutical composition |
| 02/04/2010 | WO2010012745A2 Benzimidazoles |
| 02/04/2010 | US20100029643 Heterocyclyc sulfonamides having edg-1 antagonistic activity |
| 02/04/2010 | CA2732018A1 Solid pharmaceutical composition |
| 02/03/2010 | CN100586936C Chemical synthesis of albendazole-sulfoxide |
| 02/02/2010 | US7655683 Imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | US20100022610 New Crystalline Forms |
| 01/28/2010 | US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
| 01/27/2010 | EP2146969A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/27/2010 | EP2146968A1 Urea derivatives as glutaminyl cyclase inhibitors |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/26/2010 | US7652053 Diaminocycloalkane MCH receptor antagonists |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/21/2010 | WO2010009405A2 Targeted nitroxide agents |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | US20100016393 Novel hydrogen sulfate salt |
| 01/21/2010 | US20100016372 Benzimidazole Derivatives |
| 01/21/2010 | US20100015717 Mass Tags for Quantitive Analysis |
| 01/20/2010 | EP2144882A2 Tris(heterocyclyl) metal complexes as bleach catalysts |
| 01/20/2010 | EP1831159B1 Tetralin and indane derivatives and uses thereof |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/14/2010 | WO2010006238A2 Stimulus-responsive apta-chelamers |
| 01/14/2010 | WO2010004385A1 Process for the preparation of pure 4'-[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid |
| 01/14/2010 | US20100010038 Tricyclic compound and pharmaceutical use thereof |
| 01/14/2010 | US20100010015 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 01/14/2010 | CA2730083A1 Stimulus-responsive apta-chelamers |
| 01/13/2010 | EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142513A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | CN101624376A Substituted hydrazide compound and application thereof |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645884 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof |
| 01/12/2010 | US7645785 Farnesoid-X-receptors (FXR) agonists; diabetes and dyslipidemia; 2,N-dicyclohexyl-2-(2-phenyl-benzoimidazol-1-yl)-acetamide hydrogen chloride |
| 01/12/2010 | US7645784 Benzimidazole derivatives |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | US20100004285 POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/06/2010 | EP2139866A2 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 01/06/2010 | EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642278 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 01/05/2010 | US7642277 Non-nucleoside reverse transcriptase inhibitors |
| 01/05/2010 | US7642275 Histone deacetylase inhibitors |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326029 Non-cyclic substituted benzimidazole thiophene benzyl ether compounds |
| 12/31/2009 | US20090326027 N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter Inhibitors |
| 12/31/2009 | US20090325993 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/30/2009 | WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 12/30/2009 | WO2009120874A3 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-кB ACTIVATION |
| 12/30/2009 | EP2138484A1 Fused bicyclic heteroaryl derivatives |
| 12/30/2009 | EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/24/2009 | US20090318514 Novel Pharmaceutical Compositions |
| 12/24/2009 | US20090318445 Pdf inhibitors |
| 12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 12/23/2009 | EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 12/23/2009 | CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity |